Stemline Therapeutics (STML)

Add to Watchlists
Create an Alert
5.51 +0.01  +0.18% NASDAQ Apr 29, 21:57 Delayed 2m USD
View Full Chart
STML Price Chart
View All Performance Charts

STML Total Returns Comparison

Advertisement

One Page Reports

Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • URL: http://www.stemline.com
  • Investor Relations URL: http://ir.stemline.com/
  • HQ Country: United States
  • HQ State/Province: New York
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2016
  • Est. Current Fiscal Year End: December 31, 2016
  • Last Fiscal Quarter End: December 31, 2015
  • Last Fiscal Year End: December 31, 2015
  • Next Earnings Release: N/A
  • NAICS Name: Biological Product (Except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry Name: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector Name: Manufacturing
  • Profile: Stemline Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, acquiring, developing and commercializing proprietary therapeutics that target both cancer stem cells, or CSCs, and tumor bulk.

STML Comparables

Edit

STML Excel Add-In Codes

  • Name: =YCI("STML","name")
  • Description: =YCI("STML","description")
  • Sector: =YCI("STML","sector")
  • Industry: =YCI("STML","industry")
  • Est. Current Fiscal Year End: =YCI("STML","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.